Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.
作者信息
Gohlke-Bärwolf C
机构信息
Herz Zentrum, Bad Krozingen, Germany. h.gohlke@t-online
出版信息
Heart. 2000 Nov;84(5):567-72. doi: 10.1136/heart.84.5.567.
Abstract
摘要
相似文献
1
Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery.
Heart. 2000 Nov;84(5):567-72. doi: 10.1136/heart.84.5.567.
2
Perioperative anticoagulation: looking through heparin window.
JAAPA. 2004 Jun;17(6):21-5; quiz 33-4.
3
Anticoagulation bridging around device surgery: compliance with guidelines.
Pacing Clin Electrophysiol. 2012 Dec;35(12):1480-6. doi: 10.1111/j.1540-8159.2012.03516.x. Epub 2012 Sep 14.
4
Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Italian physicians.
Blood Coagul Fibrinolysis. 2004 Oct;15(8):623-8. doi: 10.1097/00001721-200412000-00001.
5
The current status of bridging anticoagulation.
Br J Haematol. 2014 Mar;164(5):619-29. doi: 10.1111/bjh.12644. Epub 2013 Nov 13.
6
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation.
CMAJ. 2016 Mar 15;188(5):361-362. doi: 10.1503/cmaj.150867. Epub 2015 Dec 22.
7
Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
Br J Haematol. 2006 Feb;132(3):277-85. doi: 10.1111/j.1365-2141.2005.05856.x.
8
A practical approach for bridging anticoagulation after mechanical heart valve replacement.
J Heart Valve Dis. 2008 May;17(3):335-42.
9
eComment: Are low molecular weight heparin effective in mechanical valve prosthesis anticoagulation during pregnancy?
Interact Cardiovasc Thorac Surg. 2010 Jan;10(1):118-9. doi: 10.1510/icvts.2009.220806B.
10
Anticoagulation of pregnant women with mechanical heart valves using low-molecular-weight heparin.
Arch Intern Med. 2003;163(22):2788-9. doi: 10.1001/archinte.163.22.2788-b.
引用本文的文献
1
[Current recommendations for prevention of thromboembolic events in patients with heart valve prostheses].
Z Kardiol. 2001 Dec;90(Suppl 6):112-7. doi: 10.1007/s003920170018.
2
Anesthetic management of a patient with prosthetic heart valve for non-cardiac surgery: A case report.
Cases J. 2008 Sep 30;1(1):196. doi: 10.1186/1757-1626-1-196.
3
Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations.
Heart. 2007 Jan;93(1):137-42. doi: 10.1136/hrt.2005.071183.
4
Management and follow up of prosthetic heart valves.
Heart. 2004 Jul;90(7):818-24. doi: 10.1136/hrt.2003.025049.
5
Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocumarol.
Heart. 2003 May;89(5):527-30. doi: 10.1136/heart.89.5.527.
6
Present treatment options for atrial fibrillation.
Postgrad Med J. 2003 Feb;79(928):67-73. doi: 10.1136/pmj.79.928.67.
7
Choice of heart valve prosthesis.
Heart. 2002 Jun;87(6):583-9. doi: 10.1136/heart.87.6.583.
8
The medical management of valvar heart disease.
Heart. 2002 Apr;87(4):395-400. doi: 10.1136/heart.87.4.395.
9
Valve disease: Surgery of valve disease: late results and late complications.
Heart. 2001 Dec;86(6):715-21. doi: 10.1136/heart.86.6.715.
10
Fulminant thrombosis of mechanical mitral valve prosthesis.
Heart. 2001 Nov;86(5):E16. doi: 10.1136/heart.86.5.e16.
本文引用的文献
1
Low molecular weight heparin after mechanical heart valve replacement.
Circulation. 2000 Mar 14;101(10):1083-6. doi: 10.1161/01.cir.101.10.1083.
2
Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
J Heart Valve Dis. 1999 Jul;8(4):392-8.
3
A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation.
JAMA. 1999 Jan 13;281(2):145-50. doi: 10.1001/jama.281.2.145.
4
ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease).
J Am Coll Cardiol. 1998 Nov;32(5):1486-588. doi: 10.1016/s0735-1097(98)00454-9.
5
Dental surgery in anticoagulated patients.
Arch Intern Med. 1998;158(15):1610-6. doi: 10.1001/archinte.158.15.1610.
6
Correction of excessive anticoagulation with low-dose oral vitamin K1.
Ann Intern Med. 1997 Jun 15;126(12):959-62. doi: 10.7326/0003-4819-126-12-199706150-00005.
7
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves.
Circulation. 1996 Nov 1;94(9):2107-12. doi: 10.1161/01.cir.94.9.2107.
8
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.
Eur Heart J. 1995 Oct;16(10):1320-30. doi: 10.1093/oxfordjournals.eurheartj.a060739.
9
A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
N Engl J Med. 1993 Aug 19;329(8):524-9. doi: 10.1056/NEJM199308193290802.
10
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Circulation. 1994 Feb;89(2):635-41. doi: 10.1161/01.cir.89.2.635.
Zotero 插件